A precise performance-based reimbursement model for the multi-centre NAPKON cohorts - development and evaluation.

Autor: Appel KS; Goethe University Frankfurt, University Hospital, Center for Internal Medicine, Medical Department 2 (Hematology/Oncology and Infectious Diseases), Theodor-Stern-Kai 7, 60596, Frankfurt, Germany. appel@med.uni-frankfurt.de.; University of Cologne, Faculty of Medicine and University Hospital of Cologne, Department I for Internal Medicine, Cologne, Germany. appel@med.uni-frankfurt.de., Lee CH; University of Cologne, Faculty of Medicine and University Hospital of Cologne, Department I for Internal Medicine, Cologne, Germany., Nunes de Miranda SM; University of Cologne, Faculty of Medicine and University Hospital of Cologne, Department I for Internal Medicine, Cologne, Germany., Maier D; Goethe University Frankfurt, University Hospital, Center for Internal Medicine, Medical Department 2 (Hematology/Oncology and Infectious Diseases), Theodor-Stern-Kai 7, 60596, Frankfurt, Germany.; German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz and German Cancer Research Center (DKFZ), Heidelberg, Germany., Reese JP; University of Würzburg, Institute for Clinical Epidemiology and Biometry, Würzburg, Germany.; University Hospital Würzburg, Institute for medical Data Science, Würzburg, Würzburg, Germany., Anton G; Medical School OWL, Bielefeld University, Bielefeld, Germany., Bahmer T; Internal Medicine Department I, Pneumology Section, University Hospital Schleswig-Holstein Campus Kiel, Kiel, Germany.; German Center for Lung Research (DZL), Airway Research Center North (ARCN), Grosshansdorf, Germany., Ballhausen S; Internal Medicine Department I, Pneumology Section, University Hospital Schleswig-Holstein Campus Kiel, Kiel, Germany., Balzuweit B; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Infectious Diseases, Respiratory Medicine and Critical Care, Berlin, Germany., Bellinghausen C; Department I of Internal Medicine, Goethe University Frankfurt, University Hospital Frankfurt, Frankfurt, Germany., Blumentritt A; Independent Trusted Third Party of the University Medicine Greifswald, Ellernholzstraße 1-2, 17475, Greifswald, Germany., Brechtel M; University of Cologne, Faculty of Medicine and University Hospital of Cologne, Department I for Internal Medicine, Cologne, Germany., Chaplinskaya-Sobol I; Department of Medical Informatics at the University Medical Center Göttingen, Göttingen, Germany., Erber J; TUM School of Medicine and Health, Department of Clinical Medicine, Clinical Department for Internal Medicine II, Technical University of Munich, University Medical Center, Munich, Germany., Fiedler K; Goethe University Frankfurt, University Hospital, Center for Internal Medicine, Medical Department 2 (Hematology/Oncology and Infectious Diseases), Theodor-Stern-Kai 7, 60596, Frankfurt, Germany.; University of Cologne, Faculty of Medicine and University Hospital of Cologne, Department I for Internal Medicine, Cologne, Germany., Geisler R; Goethe University Frankfurt, University Hospital, Center for Internal Medicine, Medical Department 2 (Hematology/Oncology and Infectious Diseases), Theodor-Stern-Kai 7, 60596, Frankfurt, Germany.; University of Cologne, Faculty of Medicine and University Hospital of Cologne, Department I for Internal Medicine, Cologne, Germany., Heyder R; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, NUM Coordination Office, Charitéplatz 1, 10117, Berlin, Germany., Illig T; Hannover Medical School, Hannover Unified Biobank, Hannover, Germany., Kohls M; University of Würzburg, Institute for Clinical Epidemiology and Biometry, Würzburg, Germany., Kollek J; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Infectious Diseases, Respiratory Medicine and Critical Care, Clinical Trial Unit Berlin, Berlin, Germany., Krist L; Institute of Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Lorbeer R; Deutsches Herzzentrum der Charité, Institute of Computer-Assisted Cardiovascular Medicine, Berlin, Germany.; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.; Department of Radiology, Ludwig-Maximilians-University Hospital, Munich, Germany., Miljukov O; University of Würzburg, Institute for Clinical Epidemiology and Biometry, Würzburg, Germany.; University Hospital Würzburg, Institute for medical Data Science, Würzburg, Würzburg, Germany., Mitrov L; University of Cologne, Faculty of Medicine and University Hospital of Cologne, Department I for Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Cologne, Germany., Nürnberger C; University of Würzburg, Institute for Clinical Epidemiology and Biometry, Würzburg, Germany.; University Hospital Würzburg, Institute for medical Data Science, Würzburg, Würzburg, Germany., Pape C; Department of Medical Informatics at the University Medical Center Göttingen, Göttingen, Germany., Pley C; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Clinical Trial Office, Berlin, Germany., Schäfer C; Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Greifswald, Germany., Schaller J; Deutsches Herzzentrum der Charité, Institute of Computer-Assisted Cardiovascular Medicine, Berlin, Germany.; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany., Schattschneider M; Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Greifswald, Germany., Scherer M; Goethe University Frankfurt, University Hospital, Center for Internal Medicine, Medical Department 2 (Hematology/Oncology and Infectious Diseases), Theodor-Stern-Kai 7, 60596, Frankfurt, Germany., Schulze N; Goethe University Frankfurt, University Hospital, Center for Internal Medicine, Medical Department 2 (Hematology/Oncology and Infectious Diseases), Theodor-Stern-Kai 7, 60596, Frankfurt, Germany.; University of Cologne, Faculty of Medicine and University Hospital of Cologne, Department I for Internal Medicine, Cologne, Germany., Stahl D; Independent Trusted Third Party of the University Medicine Greifswald, Ellernholzstraße 1-2, 17475, Greifswald, Germany., Stubbe HC; Department of Medicine II, University Hospital, LMU Munich, Munich, Germany.; German Center for Infection Research (DZIF), Partner-Site Munich, Munich, Germany., Tamminga T; Internal Medicine Department I, Pneumology Section, University Hospital Schleswig-Holstein Campus Kiel, Kiel, Germany., Tebbe JJ; Hospital Lippe, Department of Gastroenterology and Infectious Diseases, Lippe, Germany.; Bielefeld University, Medical School OWL, Bielefeld, Germany., Vehreschild MJGT; Goethe University Frankfurt, University Hospital Frankfurt, Department II of Infectious Diseases, Frankfurt, Germany., Wiedmann S; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, NUM Coordination Office, Charitéplatz 1, 10117, Berlin, Germany., Vehreschild JJ; Goethe University Frankfurt, University Hospital, Center for Internal Medicine, Medical Department 2 (Hematology/Oncology and Infectious Diseases), Theodor-Stern-Kai 7, 60596, Frankfurt, Germany. j.vehreschild@med.uni-frankfurt.de.; University of Cologne, Faculty of Medicine and University Hospital of Cologne, Department I for Internal Medicine, Cologne, Germany. j.vehreschild@med.uni-frankfurt.de.; German Center for Infection Research (DZIF), Partner-Site Cologne-Bonn, Cologne, Germany. j.vehreschild@med.uni-frankfurt.de.

Publikováno v: Scientific reports [Sci Rep] 2024 Jun 13; Vol. 14 (1), pp. 13607. Date of Electronic Publication: 2024 Jun 13.

The protective effect of tumor necrosis factor-alpha inhibitors in COVID-19 in patients with inflammatory rheumatic diseases compared to the general population-A comparison of two German registries.

Autor: Hasseli R; Section of Rheumatology and Clinical Immunology, Department of Internal Medicine D, University Hospital Münster, Münster, Germany.; Department of Rheumatology and Clinical Immunology, Justus-Liebig University Giessen, Giessen, Germany., Hanses F; Emergency Department and Department for Infectious Diseases and Infection Control, University Hospital Regensburg, Regensburg, Germany., Stecher M; Department I of Internal Medicine, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany., Specker C; Department of Rheumatology and Clinical Immunology, KEM Kliniken Essen-Mitte, Essen, Germany., Weise T; Biocontrol Jena, Jena, Germany., Borgmann S; Department of Infectious Diseases and Infection Control, Ingolstadt Hospital, Ingolstadt, Germany., Hasselberger M; Klinikum Passau, Passau, Germany., Hertenstein B; Klinikum Bremen-Mitte, Bremen, Germany., Hower M; Department of Pneumology, Infectious Diseases, Internal Medicine and Intensive Care, Klinikum Dortmund GmbH, Dortmund, Germany., Hoyer BF; Department for Rheumatology and Clinical Immunology, University of Schleswig-Holstein, Kiel, Germany., Koll C; Department I of Internal Medicine, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany., Krause A; Department of Rheumatology, Clinical Immunology and Osteology, Immanuel Hospital Berlin, Berlin, Germany., von Lilienfeld-Toal M; Department of Hematology and Medical Oncology, University Hospital Jena, Jena, Germany., Lorenz HM; Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany., Merle U; Department of Gastroenterology and Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany., Nunes de Miranda SM; Department of Medicine II, University of Freiburg, Freiburg, Germany., Pletz MW; Institute for Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany., Regierer AC; Epidemiology Unit, German Rheumatism Research Center Berlin, Berlin, Germany., Richter JG; Department of Rheumatology, University Hospital Düsseldorf, Medical Faculty of Heinrich-Heine-University, Düsseldorf, Germany.; Hiller Research Center, University Hospital Düsseldorf, Medical Faculty of Heinrich-Heine-University, Düsseldorf, Germany., Rieg S; Division of Infectious Diseases, Department of Medicine II, University of Freiburg, Freiburg, Germany., Roemmele C; Department of Gastroenterology, Faculty of Medicine, University of Augsburg, Augsburg, Germany., Ruethrich MM; Department of Hematology and Medical Oncology, University Hospital Jena, Jena, Germany., Schmeiser T; Private Practice, Cologne, Germany., Schulze-Koops H; Division of Rheumatology and Clinical Immunology, Department of Internal Medicine IV, University of Munich, Munich, Germany., Strangfeld A; Epidemiology Unit, German Rheumatism Research Center Berlin, Berlin, Germany., Vehreschild MJGT; Department of Internal Medicine, Infectious Diseases, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany., Voit F; Department of Internal Medicine II, School of Medicine, University Hospital Rechts Der Isar, Technical University of Munich, Munich, Germany., Voll RE; Department of Rheumatology and Clinical Immunology, Faculty of Medicine, Medical Center-University of Freiburg, University of Freiburg, Freiburg, Germany., Vehreschild JJ; Department I of Internal Medicine, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.; Department II of Internal Medicine, Hematology/Oncology, Goethe University, Frankfurt, Germany., Müller-Ladner U; Department of Rheumatology and Clinical Immunology, Justus-Liebig University Giessen, Giessen, Germany., Pfeil A; Department of Internal Medicine III, University Hospital Jena, Jena, Germany.

Publikováno v: Frontiers in medicine [Front Med (Lausanne)] 2024 Mar 06; Vol. 11, pp. 1332716. Date of Electronic Publication: 2024 Mar 06 (Print Publication: 2024).

All-cause mortality and disease progression in SARS-CoV-2-infected patients with or without antibiotic therapy: an analysis of the LEOSS cohort.

Autor: Schons MJ; Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany., Caliebe A; Institute for Medical Informatics and Statistics, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.; Kiel University, Kiel, Germany., Spinner CD; School of Medicine, Department of Internal Medicine II, Technical University of Munich, University Hospital Rechts Der Isar, Munich, Germany., Classen AY; Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany.; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany., Pilgram L; Department II of Internal Medicine, Hematology/Oncology, Goethe University, Frankfurt, Frankfurt am Main, Germany., Ruethrich MM; Institute for Infection Medicine and Hospital Hygiene, University Hospital Jena, Jena, Germany., Rupp J; University Hospital Schleswig-Holstein, Lübeck, Germany., Nunes de Miranda SM; Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany., Römmele C; Internal Medicine III - Gastroenterology and Infectious Diseases, University Hospital of Augsburg, Augsburg, Germany., Vehreschild J; Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany.; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.; Department II of Internal Medicine, Hematology/Oncology, Goethe University, Frankfurt, Frankfurt am Main, Germany., Jensen BE; Clinic for Gastroenterology, Hepatology and Infectiology, University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany., Vehreschild M; Department II of Internal Medicine, Hematology/Oncology, Goethe University, Frankfurt, Frankfurt am Main, Germany., Degenhardt C; Municipal Hospital Karlsruhe, Karlsruhe, Germany., Borgmann S; Department of Infectious Diseases and Infection Control, Ingolstadt Hospital, Ingolstadt, Germany., Hower M; Department of Pneumology, Infectious Diseases and Intensive Care, Klinikum Dortmund gGmbH, Dortmund, Germany., Hanses F; Interdisciplinary Emergency Department, University Hospital Regensburg, Regensburg, Germany., Haselberger M; Department of Internal Medicine I, Passau Hospital, Passau, Germany., Friedrichs AK; Clinic for Internal Medicine I, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany. Anette.Friedrichs@uksh.de.

Publikováno v: Infection [Infection] 2022 Apr; Vol. 50 (2), pp. 423-436. Date of Electronic Publication: 2021 Oct 08.

Differential Lyn-dependence of the SHIP1-deficient mast cell phenotype.

Autor: Nunes de Miranda SM; Institute of Biochemistry and Molecular Immunology, University Clinic, RWTH Aachen University, Pauwelsstraße 30, Aachen, 52074, Germany., Wilhelm T; Institute of Biochemistry and Molecular Immunology, University Clinic, RWTH Aachen University, Pauwelsstraße 30, Aachen, 52074, Germany., Huber M; Institute of Biochemistry and Molecular Immunology, University Clinic, RWTH Aachen University, Pauwelsstraße 30, Aachen, 52074, Germany. mhuber@ukaachen.de., Zorn CN; Institute of Biochemistry and Molecular Immunology, University Clinic, RWTH Aachen University, Pauwelsstraße 30, Aachen, 52074, Germany.

Publikováno v: Cell communication and signaling : CCS [Cell Commun Signal] 2016 May 20; Vol. 14 (1), pp. 12. Date of Electronic Publication: 2016 May 20.